DanielEinhornMDFACP, FACE

PubMed

• 114 citations
  American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
  Lawrence Blonde, Guillermo E Umpierrez, S Sethu Reddy, Janet B McGill, Sarah L Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A DeFronzo, Daniel Einhorn, Rodolfo ...> ;Endocrine Practice. 2022 Oct 1
• 20 citations
  DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
  Yehuda Handelsman, John E Anderson, George L Bakris, Christie M Ballantyne, Joshua A Beckman, Deepak L Bhatt, Zachary T Bloomgarden, Biykem Bozkurt, Matthew J Budoff, ...> ;Journal of Diabetes and Its Complications. 2022 Feb 1
• 13 citations
  Fatty kidney disease: The importance of ectopic fat deposition and the potential value of imaging.
  Christian W. Mende, Daniel Einhorn> ;Journal of Diabetes. 2021 Oct 27
• 7 citations
  When to suspect hidden hypercortisolism in type 2 diabetes: a meta-analysis
  Carmen Aresta, Davide Soranna, Luca Giovanelli, Vittoria Favero, Chiara Parazzoli, Luigi Gennari, Luca Persani, Alfredo Scillitani, Lewis S. Blevins, David Brown, Dan ...> ;Endocrine Practice. 2021 Jul 26
• 95 citations
  Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of ...
  Yehuda Handelsman, Paul S. Jellinger, Chris K. Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, ...> ;Endocrine Practice. 2020 Oct 1
• 31 citations
  Concentrated Insulins: Clinical Update of Therapeutic Options
  Guillermo E. Umpierrez, Elizabeth H. Holt, Daniel Einhorn, Janet B. McGill> ;Endocrine Practice. 2020 Jun 1
• 308 citations
  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGO...
  Alan J. Garber, Yehuda Handelsman, George Grunberger, Daniel Einhorn, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Michael A. Bush, Ralph A. DeFronzo, Je...> ;Endocrine Practice. 2020 Jan 1
• Treatment of glycemic control in diabetes in the CVOT era.
  Daniel Einhorn> ;Journal of Diabetes. 2020 Jan 1
• 5 citations
  Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?
  Zachary T. Bloomgarden, Daniel Einhorn, George Grunberger, Yehuda Handelsman> ;Journal of Diabetes. 2019 May 1
• 24 citations
  FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETES.
  Christian W. Mende, Daniel Einhorn> ;Endocrine Practice. 2019 Apr 23
• 214 citations
  Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algo...
  Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Ralph A. DeFronzo, Daniel Einho...> ;Endocrine Practice. 2019 Feb 11
• 55 citations
  Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Lancet. 2018 Nov 24
• 5 citations
  American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia.
  Zachary T. Bloomgarden, Daniel Einhorn, Yehuda Handelsman, Anoop Misra, Joel Zonszein, George Grunberger, Paul S. Jellinger, Alan J. Garber> ;Journal of Diabetes. 2018 May 4
• 332 citations
  Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algo...
  Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Ralph A. DeFronzo, Daniel Einho...> ;Endocrine Practice. 2018 Jan 17
• 4 citations
  AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.
  Vivian Fonseca, Zachary T. Bloomgarden, Samuel Dagogo-Jack, George Grunberger, Daniel Einhorn, Alan J. Garber, Yehuda Handelsman, Irl B. Hirsch, Guillermo E. Umpierrez> ;Endocrine Practice. 2017 Nov 30
• Response to Comment on Bloomgarden et al. Is HbA1c 65 Years Old? Diabetes Care 2017;40:526-528.
  Zachary T. Bloomgarden, Daniel Einhorn, Yehuda Handelsman> ;Diabetes Care. 2017 Oct 1
• 133 citations
  Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project.
  Suzanne V. Arnold, Silvio E. Inzucchi, Fengming Tang, Darren K. McGuire, Sanjeev N. Mehta, Thomas M. Maddox, Abhinav Goyal, Laurence S. Sperling, Daniel Einhorn, Natha...> ;European Journal of Preventive Cardiology. 2017 Sep 5
• 18 citations
  Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry
  Suzanne V. Arnold, Abhinav Goyal, Silvio E. Inzucchi, Darren K. McGuire, Fengming Tang, Sanjeev N. Mehta, Laurence S. Sperling, Thomas M. Maddox, Daniel Einhorn, Natha...> ;Journal of the American Heart Association. 2017 Aug 11
• 12 citations
  Is HbA1c 65 Years Old
  Zachary T. Bloomgarden, Daniel Einhorn, Yehuda Handelsman> ;Diabetes Care. 2017 Apr 1
• Diabetes treatment over age 65: Is worse control really better?
  Zachary T. Bloomgarden, Christian W. Mende, Daniel Einhorn, Yehuda Handelsman> ;Journal of Diabetes. 2017 Feb 28
• 319 citations
  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGO...
  Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Ralph A. DeFronzo, Daniel Einho...> ;Endocrine Practice. 2017 Feb 15
• 7 citations
  Revisiting The Use of Pioglitazone in the Treatment of Type 2 Diabetes
  Daniel Einhorn, Vivian Fonseca> ;Endocrine Practice. 2016 Nov 28
• 29 citations
  Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry.
  Suzanne V. Arnold, Silvio E. Inzucchi, Darren K. McGuire, Sanjeev N. Mehta, Abhinav Goyal, Laurence S. Sperling, Thomas M. Maddox, Daniel Einhorn, Nathan D. Wong, Robe...> ;Diabetes Care. 2016 Jul 1
• 215 citations
  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACI...
  Yehuda Handelsman, Robert R. Henry, Zachary T. Bloomgarden, Samuel Dagogo-Jack, Ralph A. DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian Fonseca, Alan J. Garber, Geor...> ;Endocrine Practice. 2016 Jun 1
• 614 citations
  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGO...
  Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Ralph A. DeFronzo, Daniel Einho...> ;Endocrine Practice. 2016 Jan 5
• Join now to see all

Journal Articles

• The Clinical Approach to the Detection of Lipodystrophy – An AACE Consensus Statement  
  Yehuda Handelsman, MD, FACP, FACE, FNLA; Elif A. Oral, MD, FACE; Zachary T. Bloomgarden, MD, FACE; Rebecca J. Brown, MD4; Jean L. Chan, MD; Daniel Einhorn, MD, FACP, F..., Endocr Pract, 1/1/2013
• Comprhensive Diabetes and Cardiovascular Treatment = Sugar + Blood Pressure + Lipids  
  Bloomberg, Z., Yehuda, H., Einhorn, D., Journal of Diabetes, 12/1/2011
• Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids  
  Zachary Bloomgarden, Yehuda Handelsman, Daniel Einhorn, Multiple locations, 2011, 9/1/2011
• AACE/ACE Statement on the use of Hemoglobin A1C for the diagnosis of diabetes  
  Bloomgarden, Z., Bray, G., Davidson, J., Einhorn, D., Endocrine Practice, 3/1/2010
• The Navigator Study Group, Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events  
  Einhorn, Daniel, The New England Journal of Medicine, 1/1/2010
• Statement by an American Association of Clinical Ensocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algoristhm for Gly...  
  Einhorn, D., Rodbard, H., Tellinger, P., Davidson, J., Garber, A., Grunberger, G., Handelsman, Y., Horton, E., Lebovitz, H., Levy, P., Moghissi, E., Schwartz, S., Endocrine Practice, 9/1/2009
• American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control  
  Enhorn, D., Moghissi, E.., Korytkowski, M., DiNardo, M., Heltman, R., Hirsch, I., Inzucchi, S., Ismail-Beigi, F., Kirkman, S., Umpierrez, G., Endocrine Practice, 5/1/2009
• Statement by an AACE/ACE Consensus Panel on type 2 Mellitus: A Glycemic Control Algorithm  
  Rodbard, H., Jellinger, P., Davidson, J., Einhorn, D., Endocrine Practice, 1/1/2009
• Diagnosis and Management of Prediabetes in the continuum of Hyperglycemia-When do the Risks of Diabetes Begin? A Consensus Statement from The American College of Endoc...  
  Garber, A., Yehuda, H., Einhorn, D., Bergman, D., et al., Endocrine Practice, 10/1/2008
• The Metobolic Syndrome and the Clinician  
  Einhorn, D., Drug Development Research, 7/1/2006
• Endocrine and Metabolism Clinics of North America: Type 2 Diabetes, A Cardiovascular Disease  
  3/1/2005
• The American College of Endocrinology Position Paper on the Insulin Resistance Syndrome  
  Einhorn, D., Executive Summary, Endocrine Practice, 3/1/2003
• Effects of Insulin In Relatives of Patients With Type 1 Diabetes Mellitus  
  The New England Journal of Medicine, 5/30/2002
• Efficacy and Safety of Pioglitazone Hydrochloride in Insulin-Treated Type II Diabetes: A Randomized, Placebo-Controlled Study  
  Julio Rosenstock, MD; Daniel Einhorn, MD; Kenneth Hershon, MD; N Bradly Glazer, Pharm D; Shawn Yu, Ph D; and The Pioglitazone 014 Study Group, International Journal of Clinical Practice, 5/1/2002
• The Ibersartan Type II Diabetic Nephropathy Trial: Study Design and Baseline Patient Characteristics  
  Rodby, Roger, et al and The Collaborative Study Group, Nephrology, Dialysis, Transplantation, 4/1/2000
• Diet, Exercise Remain Basis for Preventing Diabetes  
  Einhorn, Daniel, Internal Medicine World Report, 1/1/2000
• Pioglitazone Hydrochloride in Combination with Metformin Therapy Improves Glycemic Control in the Treatment of Patients with Type 2 Diabetes Mellitus: A Randomized, Pl...  
  Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL., Clinical Therapeutics, 1/1/2000
• A Randomized Placebo-Controlled Trial of Repaglinide in the Treatment of Type 2 Diabetes  
  Lead author, Einhorn, Daniel, et al., Diabetes Care, 11/1/1998
• Reviewer, AACE/ACE Physicians Statement on Prevention, Diagnosis and Treatment of Obesity (1998 Rev)  
  Endocrine Practice, 9/1/1998
• Tailoring Insulin Regimens for Type 2 Diabetes Mellitus  
  Sadler, Chris PA, Einhorn, D., JAAPA, 4/1/1998
• Effect of Premixed NPH and Regular Insulin on Glucose Control and Health-Related Quality of Life in Patients with Type 2 Diabetes Mellitus  
  Davidson, J., Einhorn, D., Allweiss, P., Flood, T., Garber, A., Garcia, M., Kahn, C., Soler, N., White, J., Huster, W., Endocrine Practice, 11/1/1997
• New Strategies for Treatment of Type II diabetes  
  Einhorn, Daniel, The Journal of Family Practice Recertification, 8/1/1997
• New Strategies For Treatment of Type I Diabetes  
  Einhorn, Daniel, The Journal of Family Practice Recertification, 2/1/1997
• The Effect of Premixed NPH and Regular Insulin on Glucose Control and Health-related Quality of Life in Patients with Type 2 diabetes mellitus  
  Davidson, Jr., Einhorn, D., et al., Endocrine Practice, 1/1/1997
• Thyroid Cancer Task Force  
  Hay, Ian, M.D.(Einhorn, Daniel Reviewer), Endocrine Practice, 1/1/1997
• Join now to see all

Books/Book Chapters

• Endocrinology and Metabolism Clinics of North America 
  Chapter: Glitazones: Uses and Potential Uses for Treatment of Insulin Resistance 
  Einhorn, D., Aroda, V. and Henry, R.Elsevier, Saunders2004
• Clinical Endocrinology Update 
  Chapter: Nuts & Bolts of Intensive Insulin Therapy 
  Einhorn, DanielEditors: Dillman, N., Wolfgang.Endocrine Society Press1995
• Insulin Pumping 
  Chapter: Introduction 
  Einhorn, D.Editors: Walsh and Roberts.MiniMed1990
• Modern Nutrition in Health and Disease 
  Chapter: Nutrition and Diet in Hypertension 
  Einhorn, D., Landsberg, L.Lea and FabigerEdition 8th ,1988
• Join now to see all

Abstracts/Posters

• Hypoglycemia in type 2 diabetes: current controversies and changing practices
  Zachary T Bloomgarden, Daniel Einhorn, Mount Sinai School of Medicine New York, Frontiers in endocrinology, NY, USA, 1/1/2012
• Comprehensive Diabetes and Cardiovascular Treatment = Sugar + Blood Pressure + Lipids
  Bloomberg, Z., Yehuda, H., Einhorn, D., Journal of Diabetes, 12/1/2011
• AACE/ACE Statement on the use of Hemoglobin A1C for the diagnosis of diabetes
  Bloomgarden, Z., Bray, G., Davidson, J., Einhorn, D., Endocrine Practice, 3/1/2010
• Statement by an American Association of Clinical Ensocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algoristhm for Gly...
  Einhorn, D., Rodbard, H., Tellinger, P., Davidson, J., Garber, A., Grunberger, G., Handelsman, Y., Horton, E., Lebovitz, H., Levy, P., Moghissi, E., Schwartz, S., Endocrine Practice, 9/1/2009
• American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
  Enhorn, D., Moghissi, E.., Korytkowski, M., DiNardo, M., Heltman, R., Hirsch, I., Inzucchi, S., Ismail-Beigi, F., Kirkman, S., Umpierrez, G., Endocrine Practice, 5/1/2009
• Statement by an AACE/ACE Consensus Panel on type 2 Mellitus: A Glycemic Control Algorithm
  Rodbard, H., Jellinger, P., Davidson, J., Einhorn, D., Endocrine Practice, 1/1/2009
• Diagnosis and Management of Prediabetes in the continuum of Hyperglycemia-When do the Risks of Diabetes Begin? A Consensus Statement from The American College of Endoc...
  Garber, A., Yehuda, H., Einhorn, D., Bergman, D., et al., Endocrine Practice, 10/1/2008
• Prevalence of Sleep Apnea in a Population of Adults with Type 2 Diabetes
  Einhorn, D., Erman, M., Stewart, D., Gordon, N., and Tsimika, P., ADA Annual Scientific Meeting, San Diego, 6/1/2006
• Use of OneTough UltraSmart System is Associated with an Enhanced Reduction of Hemoglobin A1c
  Joslin Diabetes Center, Washington University School of Medicine, University of Miami School of Medicine, Childrens Hospital Los Angeles, University of Maryland School of Medicine, Diabetes & Endocrine Associates, La Jolla, CA, 4/1/2005
• Long-term Pioglitazone Treatment Decreases Insulin Resistance and Improves Beta-cell Function in type 2 Diabetes
  W Cheatham, D Einhorn, KE Robertson, United Kingdom Diabetes Meeting, Birmingham, 3/1/2002
• Durability of Glycemic Control with Pioglitazone/Metformin Combination Therapy in type 2 Diabetes
  NB Glazer, A Perez, D Einhorn, United Kingdom Diabetes Meeting, Birmingham, 3/1/2002
• For the Pioglitazone Study Group. Long Term Durability of Control With Piogliazone Alone and in Combination with Metformin, Sulfonylurea, or Insulin
  Einhorn, D., Kipnis, M., Glazer, B., American Diabetes Association Annual Scientific Sessions, Philadelphia, PA, 6/1/2001
• Pioglitazone Hydrochloride in Combination with Metformin Therapy Improves Glycemic Control in the Treatment of Patients with Type 2 Diabetes Mellitus: A Randomized, Pl...
  Daniel Einhorn, MD, Marc Rendell, MD, James Rosenzweig, MD, John W. Egan, Annette L. Mathisen, PhD, Roberta L. Schneider, MD, and The Pioglitazone 027 Study Group, AACE Annual Meeting, San Antonio, TX, 5/1/2001
• New Insights on Glycemic Control in the Ambulatory Setting: MiniMed’s Continuous Glucose Monitoring System
  Einhorn, D., Sadler, C., and Fink, R., The Endocrine Society 82nd Annual Meeting, Toronto, Ontario, 6/1/2000
• The Treament of Diabetes: A Practitioners Guide (Parts 1 and 2)
  The American Medical Association. The Diabetes CME Advisory Committee, AMA Publications, 1/1/2000
• Effect of Premixed NPH and Regular Insulin on Glucose Control and Health-Related Quality of Like in Patients with Type 2 Diabetes Mellitus
  Einhorn, D., Davidson, J., Allweiss, P., Flood, T., Garber, A., Garcia, M., Kahn, C., Soler, N., White, J., Huster, W., 12/1/1997
• Effects of an anti-CDS Immunoconjugate (CD5-plus) in Recent Onset Type 1 Diabetes Mellitus
  Skyler, J.S., Lorenz, T., Schwartz, S., Eisenbarth, G.S., Einhorn, E., Palmer, J.P., Marks, J.B., Greenbaum, C., Saria E.A., Byers, V., American Diabetes Association Annual Scientific Sessions, 1/1/1994
• Short Term Insulin Therapy Can Restore Responsiveness to Glyburide in NIDDM.
  Fink, R.I., Einhorn, D., Gold, E.N., Humphries, D., American Diabetes Association Annual Scientific Sessions, Atlanta, 1/1/1990
• Microalbuminuria in Insulin Dependent Diabetes; Comparison of First Voided Morning Urine with Timed Urine Specimens
  Norris, R.M., Dunn, G.H., Laverdiere, J., Spittell, L.K., Fink, R.I., Einhorn, D., American Diabetes Association Annual Scientific Sessions, New Orleans, 1/1/1988
• Decreased Sympathetic Activity in Brown Adipose Tissue of Streptozotooin -Treated Rats
  Einhorn, D., Young, J.B., Landsberg, L., American Diabetes Association Annual Scientific Sessions, San Antonio, 1/1/1983
• Hypotensive Effect of Fasting; Mechanisms in the Spontaneously Hypertensive Rat
  Einhorn, D., Young, J.D., Landsberg, L., American Federation of Clinical Research, Washington, 1/1/1981
• Join now to see all

Lectures

• Extreme Insulin Resistance: New Stratedies 
  5/2/2013
• Individualizing Diabetes Care 
  5/1/2013
• Cardiovascular Consequences of Sleep Disturbances 
  1/1/2013
• Continuous Glucose Monitoring – Promises and Pitfalls 
  Seattle, WA, 2007; Orlando, FL, 2008 - 1/1/2008
• Pre-Diabetes: The Continuum of Risk 
  Houston, TX - 1/1/2008
• New Concepts in Diabetes Management 
  Laguna Nigel - 12/19/2007
• Insulin Therapy Review 
  12/18/2007
• Sleep Disturbance in Type 2 Diabetes 
  12/18/2007
• Incretin Therapy – Sitagliptin 
  Multiple locations, 2007 - 12/4/2007
• Review of Diabetes 2007 
  Palm Desert - 9/30/2007
• New Advances in Management of Type 2 Diabetes 
  Anaheim, CA - 9/8/2007
• Interstitial Glucose Monitoring 
  Glacier, MO - 8/18/2007
• Review of Thyroid 2007 
  8/3/2007
• Incretin Therapy – Exenatide 
  Newport Beach - 7/25/2007
• ACTOS and Cardiovascular Disease 
  Orange County - 5/30/2007
• TZDs, Type 2 Diabetes, and Cardiovascular Disease 
  Laguna Niguel - 5/4/2007
• Incretins in the Management of Type 2 Diabetes 
  Seattle, WA - 1/1/2007
• Understanding the Use of Incretins 
  12/7/2006
• Incretins in Management of Diabetes 
  12/6/2006
• Understanding Exenatide and its Clinical Uses 
  11/14/2006
• Power to Know TV program on Insulin Resistance 
  10/3/2006
• Impact of Sleep Disorders on Insulin Resistance and Diabetes 
  8/1/2006
• Implications of the PROactive Trail for Cardiology 
  6/16/2006
• Clinical Management of Insulin Resistance 
  Long Beach, CA - 5/20/2006
• Understanding the Endocannabenoid System 
  5/4/2006
• Join now to see all

Other

• An Uncomplicated Guide to Diabetes 
  Einhorn, D., American Diabetes Association
  1/1/2009
• Diabetes in a Time of Pandemic 
  
  1/1/2008
• Review of Insulin Therapy 
  UCSD Television, Take Care of Your Diabetes, Steven Edelman
  8/10/2007
• Diabetes Week TV interviews 
  NBC, Fox, KPBS
  10/29/2006
• IDEAS Teleweb conferences on Insulin Therapy 
  
  9/14/2006
• Clinical Management of Insulin Resistance (teleconferences) 
  
  1/6/2006
• Introduction to Byetta (Exenatide). DVD Recording 
  
  1/1/2005
• New Understanding of the Causes and Consequences of the Insulin Resistance Syndrome 
  National Diabetes Education Initiative, Teleconference
  11/12/2003
• Uses of Humalog 75/25 
  Teleconference
  4/3/2002
• New Considerations with TZDs 
  Teleconference
  4/1/2002
• Use of Pre-mixed Insulin 75/25 
  Eli Lilly Teleconference
  2/21/2002
• Pioglitazone Teleconference 
  
  6/1/2000
• New Insulin Strategies; Audioconference 
  
  4/20/2000
• New Insulins, New Science of Post-Prandial Control 
  Audioconference
  4/4/2000
• New Developments in the Treatment of Type 2 Diabetes 
  Educational Television
  2/12/2000
• New Strategies for Type 2 Diabetes 
  Teleconference
  11/29/1999
• New Insulins 
  Teleconference
  11/18/1999
• Management of Diabetic Neuropathy 
  Living With Diabetes T.V. Interview
  10/23/1992
• Host, "Living Well With Diabetes" 
  National Radio Show, for Pat Gallagher
  10/13/1991
• HDL Cholesterol Management 
  
  Scripps Clinic - 8/27/1991
• Host, "Living With Diabetes" 
  Radio show, Pat Gallagher, KCEO radio
  4/20/1991
• Diabetes Research 
  Living With Diabetes television broadcast, Pat Gallagher, Lifetime Cable Network, 1990; Channel 8 Ne
  San Diego, CA, 1991 - 4/11/1991
• "Advances in Diabetes", on "Male Medicine" 
  Cox Cable Television
  2/16/1991
• Advances In Diabetes Research 
  Sun-Up San Diego, Channel 8 News
  4/26/1990
• Celebrity Chef 
  
  4/23/1990
• Join now to see all